Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mallinckrodt PLC MNKTQ

Healthcare
Mallinckrodt plc develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and... see more

Recent & Breaking News (OTCPK:MNKTQ)

Mallinckrodt Deadline Alert

Newsfile August 6, 2023

MALLINCKRODT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options

PR Newswire August 5, 2023

Mallinckrodt Shareholder Notice

Newsfile August 4, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK

PR Newswire August 4, 2023

MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit

PR Newswire August 4, 2023

Mallinckrodt Shareholder Action Reminder

Newsfile August 3, 2023

Mallinckrodt Deadline Alert

Newsfile August 2, 2023

Mallinckrodt Shareholder Notice

Newsfile August 1, 2023

MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit

PR Newswire August 1, 2023

Mallinckrodt Shareholder Action Reminder

Newsfile July 31, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK

Newsfile July 31, 2023

Mallinckrodt Deadline Alert

Newsfile July 30, 2023

MALLINCKRODT SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options

PR Newswire July 29, 2023

Mallinckrodt Shareholder Action Reminder

Newsfile July 28, 2023

Mallinckrodt Shareholder Notice

Newsfile July 26, 2023

Mallinckrodt Shareholder Action Reminder

Newsfile July 25, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK

PR Newswire July 25, 2023

Mallinckrodt Deadline Alert

Newsfile July 24, 2023

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)

Business Wire July 24, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK

Newsfile July 23, 2023